AI Article Synopsis
Article Abstract
Metabolic reprogramming of purine biosynthesis is a hallmark of cancer metabolism and represents a critical vulnerability. The enzyme phosphoribosylformylglycinamidine synthase (PFAS) catalyzes the fourth step in de novo purine biosynthesis and has been demonstrated to be prognostic for survival of liver cancer. Despite the importance of this protein as a drug target, there are no known specific inhibitors of PFAS activity. Here, we describe a new continuous, spectrophotometric assay for the synthase domain of PFAS that is amenable to high-throughput screening (HTS). This mechanism-based fluorescent assay makes use of the acid phosphatase substrate, 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP). PFAS catalyzes the turnover of DiFMUP with a K of 108 ± 7 µM. After optimization and miniaturization of the assay for 1,536-well format, we conducted a pilot HTS using the LOPAC library. The assay performed extremely well, with an average Z´ of 0.94 ± 0.02, average signal to noise of 5.01 ± 0.06, excellent inter plate correlation, and a hit rate of 1.18%. This assay provides a critically needed tool to advance the study of PFAS enzymology and will be foundational for the discovery of small molecule inhibitors both as functional probes and for the basis of new drug development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.slasd.2025.100212 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A high throughput assay for phosphoribosylformylglycinamidine synthase.
SLAS Discov
January 2025
The Hormel Institute, University of Minnesota, Austin, MN 55912. Electronic address:
Metabolic reprogramming of purine biosynthesis is a hallmark of cancer metabolism and represents a critical vulnerability. The enzyme phosphoribosylformylglycinamidine synthase (PFAS) catalyzes the fourth step in de novo purine biosynthesis and has been demonstrated to be prognostic for survival of liver cancer. Despite the importance of this protein as a drug target, there are no known specific inhibitors of PFAS activity.
View Article and Find Full Text PDFActivation of Imprinted Gene Promotes Cardiac Fibrosis After Ischemic Injury.
Circulation
December 2024
School of Life Science and Technology (S.K., D.D., M.Y., Y.S., T.F., Z.J., J.M., C.L., X.L., H.Z.).
Background: Cardiac fibrosis, characterized by excessive extracellular matrix (ECM) deposition in the myocardium, is an important target for heart disease treatments. (paternally expressed gene 3) is an imprinted gene expressed from the paternal allele, and de novo purine biosynthesis (DNPB) is a crucial pathway for nucleotide synthesis. However, the roles of PW1 and DNPB in ECM production by cardiac fibroblasts during myocardial ischemia are not yet understood.
View Article and Find Full Text PDFPFAS promotes colorectal cancer progression via regulating RIG-I-mediated innate immune signalling.
Mol Immunol
December 2024
The First Affiliated Hospital, Department of Gynaecology and Obstetrics, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Electronic address:
Objective: Phosphoribosylformylglycinamidine synthase (PFAS) is a critical enzyme in de novo synthesis of purine. Innate immunity recognizes tumor derived damage-associated molecular patterns (DAMPs) and initiates the anti-tumor adaptive responses. While the function of PFAS catalyzed de novo synthesis of purine is well proved, its effect on innate immune evasion in cancer is unclear and needs to be further explored.
View Article and Find Full Text PDFNSUN2-mediated m C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression.
Clin Transl Med
May 2023
Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Background: The precise temporal and spatial regulation of N -methylcytosine (m C) RNA modification plays essential roles in RNA metabolism, and is necessary for the maintenance of epigenome homeostasis. Howbeit, the mechanism underlying the m C modification in carcinogenesis remains to be fully addressed.
Methods: Global and mRNA m C levels were determined by mRNA isolation and anti-m C dot blot in both retinoblastoma (RB) cells and clinical samples.
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension.
Pharmacogenet Genomics
June 2022
Department of Medicine, University of Chicago, Chicago, Illinois.
Objective: Prostacyclin infusion for pulmonary arterial hypertension (PAH) is an effective therapy with varied dosing requirements and clinical response. The major aim of this study was to determine new biologically-based predictors of prostacyclin treatment response heterogeneity.
Methods: Ninety-eight patients with hemodynamically defined PAH at two academic medical centers volunteered for registry studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!